Clariant AG (Muttenz, Switzerland) has signed an agreement to acquire the remaining 70% in Brazilian Personal Care Specialties company Beraca from the founding Sabará family. Clariant has held a 30% stake in the company since 2015. The purchase price will not be disclosed. The acquisition is subject to regulatory approvals and is expected to close in Q4 2021.
Beraca is one of the key manufacturers of natural ingredients for the personal care sector offering inter alia fats, oils and botanicals, which are all collected and extracted in an environmentally sustainable production process. Located in the Amazon region, Beraca promotes the development of communities, making them part of the Personal Care business on a global scale while simultaneously being strongly committed to sustainability and fair trade processes. In more than 30 years since its foundation, Beraca has received several awards and recognition from customers and institutions as a leading company in ethical sourcing aspects for Personal Care ingredients. Since 2015, Beraca has invested significant resources in expanding research and innovation and has steadily increased production capacity. With around 90 employees, the family-run company generated sales of $15 million in 2020.
“With its focus on sustainable products and processes, Beraca fits perfectly into Clariant’s portfolio,” emphasizes Conrad Keijzer, CEO of Clariant. “We gain valuable access to natural materials based on the biodiversity of the Brazilian rainforest. This opens up great opportunities for high-quality growth for our Care Chemicals business.”
“There is an increasing demand for ethically produced products on the world market, which we can meet even better with this acquisition,” says Christian Vang, Head of Business Unit Industrial & Consumer Specialties. He welcomes the Beraca team: “The excellent and highly creative team has written an extraordinary success story over the past five years, which we now want to continue and further develop under the Clariant umbrella.”
The acquisition of the remaining 70% in Beraca is a relevant building block in the strategy of further strengthening individual core business areas through targeted acquisitions. Beraca’s business will be integrated into the Care Chemicals Business Area.